The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms

Experimental Dermatology

Volumn 19, Issue 10, 2010, Pages 860-864

  Pinczewski, Joel ^a,b   Slominski, Andrzej ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Cancer; Melanocytic; Melanoma; Nevi; Vitamin D

Indexed keywords

VITAMIN D;

ARTICLE; BIOSYNTHESIS; HUMAN; MELANOMA; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; SKIN TUMOR;

HUMANS; MELANOMA; RISK FACTORS; SKIN NEOPLASMS; VITAMIN D;

EID: 79952109027     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2010.01169.x     Document Type: Article

References (100)

1. Weinstock M A. Arch Dermatol 1997: 133: 1207-1209.
2. Shepherd C, Puzanov I, Sosman J A. Curr Oncol Rep 2010: 12: 146-152.
3. Bikle D. J Nutr 2004: 134: 3472S-3478S.
4. Bikle D, Oda Y, Xie Z. J Steroid Biochem Mol Biol 2005: 97: 83-91.
5. Lehmann B, Querings K, Reichrath J. Exp Dermatol 2004: 13 (Suppl. 4): 11-15.
6. Holick M. N Engl J Med 2007: 357: 266-281.
7. Berger U, Wilson P, McClelland R A et al. J Clin Endocrinol Metab 1988: 67: 607-613.
8. Abdel-Malek Z, Ross R, Trinkle L et al. J Cell Physiol 1988: 136: 273-280.
9. Holick M. J Cell Biochem 2003: 88: 296-307.
10. Lehmann B. Exp Dermatol 2009: 18: 97-108.
11. Lehmann B, Tiebel O, Meurer M. Arch Dermatol Res 1999: 291: 507-510.
12. Zehnder D, Bland R, Williams M C et al. J Clin Endocrinol Metab 2001: 86: 888-894.
13. Frankel T, Mason R S, Hersey P et al. J Clin Endocrinol Metab 1983: 57: 627-631.
14. Schuster I E, Reddy G S, Schmid J A et al. Anticancer Res 2006: 26: 2653-2668.
15. Bikle D D. J Invest Dermatol 2008: 128: 2357-2361.
16. Gandini S, Sera F, Cattaruzza M S et al. Eur J Cancer 2005: 41: 45-60.
17. Elwood J, Gallagher R P, Hill G B et al. Int J Cancer 1985: 35: 427-433.
18. Rigel D S. J Am Acad Dermatol 2008: 58: S129-S132.
19. Noonan F, Recio J A, Takayama H et al. Nature 2001: 413: 271-272.
20. Vollmer R T. Am J Clin Pathol 2007: 128: 260-264.
21. Berwick M, Armstrong B K, Ben-Porat L et al. J Natl Cancer Inst 2005: 97: 195-199.
22. Autier P, Severi G, Boniol M et al. J Natl Cancer Inst 2005: 97: 1159; author reply 1159-1160.
23. Kalish R. J Natl Cancer Inst 2005: 97: 1158; author reply 1159-1162.
24. Dellavalle R, Johnson K R. J Natl Cancer Inst 2005: 97: 1158.
25. Fears T, Tucker M A. J Natl Cancer Inst 2005: 97: 1789-1790.
26. Hornbuckle J, Culjak G, Jarvis E et al. Melanoma Res 2003: 13: 105-109.
27. Gray-Schopfer V, Wellbrock C, Marais R. Nature 2007: 445: 851-857.
28. Curtin J, Fridlyand J, Kageshita T et al. N Engl J Med 2005: 353: 2135-2147.
29. Curtin J, Busam K, Pinkel D et al. J Clin Oncol 2006: 24: 4340-4346.
30. Mocellin S, Nitti D. Cancer 2008: 113: 2398-2407.
31. Randerson-Moor J, Taylor J C, Elliott F et al. Eur J Cancer 2009: 45: 3271-3281.
32. Kabigting F, Nelson F P, Kauffman C L et al. Dermatol Online J 2009: 15: 3.
33. Slominski A, Tobin D J, Shibahara S et al. Physiol Rev 2004: 84: 1155-1228.
34. Runger T M. Photodermatol Photoimmunol Photomed 1999: 15: 212-216.
35. Zbytek B, Wortsman J, Slominski A. Mol Endocrinol 2006: 20: 2539-2547.
36. Yasumoto K, Yokoyama K, Takahashi K et al. J Biol Chem 1997: 272: 503-509.
37. Slominski A, Wortsman J. Endocr Rev 2000: 21: 457-487.
38. Hosoi J, Abe E, Suda T et al. Cancer Res 1985: 45: 1474-1478.
39. Mansur C, Gordon P R, Ray S et al. J Invest Dermatol 1988: 91: 16-21.
40. Watabe H, Soma Y, Kawa Y et al. J Invest Dermatol 2002: 119: 583-589.
41. Tomita Y, Torinuki W, Tagami H. J Invest Dermatol 1988: 90: 882-884.
42. Oikawa A, Nakayasu M. FEBS Lett 1974: 42: 32-35.
43. Pavlovitch J, Rizk M, Balsan S. Mol Cell Endocrinol 1982: 25: 295-302.
44. Katayama I, Ashida M, Maeda A et al. Eur J Dermatol 2003: 13: 372-376.
45. Hughes P, Brown G. J Cell Biochem 2006: 98: 590-617.
46. Buitrago C, Pardo V G, De Boland A R et al. J Biol Chem 2003: 278: 2199-2205.
47. Hemesath T J P E, Takemoto C, Badalian T et al. Nature 1998: 391: 298-301.
48. Wu M, Hemesath T J, Takemoto C M et al. Genes Dev 2000: 14: 301-312.
49. An H, Yoo J Y, Lee M K et al. Photodermatol Photoimmunol Photomed 2001: 17: 266-271.
50. Brozyna A, Zbytek B, Granese J et al. Expert Rev Dermatol 2007: 2: 451-469.
51. Swope V, Medrano E E, Smalara D et al. Exp Cell Res 1995: 217: 453-459.
52. De Luca M, Siegrist W, Bondanza S et al. J Cell Sci 1993: 105 (Pt 4): 1079-1084.
53. Cardones A, Grichnik J M. Arch Dermatol 2009: 145: 441-444.
54. Florell S, Bowen A R, Hanks A N et al. J Cutan Pathol 2005: 32: 45-49.
55. Patton E, Widlund H R, Kutok J L et al. Curr Biol 2005: 15: 249-254.
56. Lin J, Takata M, Murata H et al. J Natl Cancer Inst 2009: 101: 1423-1427.
57. Pollock P, Harper U L, Hansen K S et al. Nat Genet 2003: 33: 19-20.
58. Carli P, Massi D, Santucci M et al. J Am Acad Dermatol 1999: 40: 549-557.
59. Bogdan I, Smolle J, Kerl H et al. Melanoma Res 2003: 13: 213-217.
60. Li F, Ling X, Huang H et al. Oncogene 2005: 24: 1385-1395.
61. Liu G, Hu X, Chakrabarty S. Int J Cancer 2010: 126: 631-639.
62. Hong S P, Kim M J, Jung M Y et al. J Invest Dermatol 2008: 128: 2880-2887.
63. Chatterjee M. Mutat Res 2001: 475: 69-87.
64. Damian D, Kim Y J, Dixon K M et al. Exp Dermatol 2010: 19: e23-30.
65. Friedman R, Farber M J, Warycha M A et al. Clin Dermatol 2009: 27: 103-115.
66. Osborne J, Hutchinson P E. Br J Dermatol 2002: 147: 197-213.
67. Chudnovsky Y, Khavari P A, Adams A E. J Clin Invest 2005: 115: 813-824.
68. Cordero J, Cozzolino M, Lu Y et al. J Biol Chem 2002: 277: 38965-38971.
69. Worm M, Makki A, Dippel E et al. Exp Dermatol 1995: 4: 30-35.
70. Verlinden L, Verstuyf A, Convents R et al. Mol Cell Endocrinol 1998: 142: 57-65.
71. Danielsson C, Fehsel K, Polly P et al. Cell Death Differ 1998: 5: 946-952.
72. Grossman D, McNiff J M, Li F et al. J Invest Dermatol 1999: 113: 1076-1081.
73. Mamori S, Kahara F, Ohnishi K et al. Scand J Gastroenterol 2009: 44: 1497-1498.
74. Liu T, Brouha B, Grossman D. Oncogene 2004: 23: 39-48.
75. Yan H, Thomas J, Liu T et al. Oncogene 2006: 25: 6968-6974.
76. Reichrath J, Rech M, Seifert M. J Pathol 2003: 201: 335-336.
77. Shannan B, Seifert M, Leskov K et al. Anticancer Res 2006: 26: 2707-2716.
78. Busam K, Kucukgol D, Eastlake-Wade S et al. J Cutan Pathol 2006: 33: 619-623.
79. Colston K, Colston M J, Feldman D. Endocrinology 1981: 108: 1083-1086.
80. Seifert M, Rech M, Meineke V et al. J Steroid Biochem Mol Biol 2004: 80-90: 375-379.
81. Reichrath J, Rech M, Moeini M et al. Cancer Biol Ther 2007: 6: 48-55.
82. Zinser G, Sundberg J P, Welsh J. Carcinogenesis 2002: 23: 2103-2109.
83. Zinser G, Suckow M, Welsh J. J Steroid Biochem Mol Biol 2005: 97: 153-164.
84. Chung I, Han G, Seshadri M et al. Cancer Res 2009: 69: 967-975.
85. Nurnberg B, Graber S, Gartner B et al. Anticancer Res 2009: 29: 3669-3674.
86. Newton-Bishop J, Beswick S, Randerson-Moor J et al. J Clin Oncol 2009: 27: 5439-5444.
87. Albertson D, Ylstra B, Segraves R et al. Nat Genet 2000: 25: 144-146.
88. Parise R, Egorin M J, Kanterewicz B et al. Int J Cancer 2006: 119: 1819-1828.
89. Koynova D, Jordanova E S, Milev A D et al. Melanoma Res 2007: 17: 37-41.
90. Reichrath J, Rafi L, Rech M et al. J Steroid Biochem Mol Biol 2004: 80-90: 163-166.
91. Slominski A. Pigment Cell Melanoma Res 2009: 22: 154-155.
92. Schulman J, Fisher D E. Curr Opin Oncol 2009: 21: 144-149.
93. Beer T, Myrthue A. Mol Cancer Ther 2004: 3: 373-381.
94. Beer T, Myrthue A. Anticancer Res 2006: 26: 2647-2651.
95. Blanke C, Beer T M, Todd K et al. Invest New Drugs 2009: 27: 374-378.
96. Slominski A, Semak I, Wortsman J et al. FEBS J 2006: 273: 2891-2901.
97. Slominski A, Zjawiony J, Wortsman J et al. Eur J Biochem 2004: 271: 4178-4188.
98. Slominski A T, Zmijewski M A, Semak I et al. PLoS ONE 2009: 4: e4309.
99. Tuckey R C, Li W, Zjawiony J K et al. FEBS J 2008: 275: 2585-2596.
100. Zmijewski M A, Li W, Zjawiony J K et al. Steroids 2009: 74: 218-228.